Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 3
1978 5
1979 4
1980 4
1981 3
1982 2
1983 3
1984 4
1985 5
1986 6
1987 3
1988 6
1989 6
1990 1
1991 7
1992 10
1993 8
1994 10
1995 5
1996 3
1997 2
1998 5
1999 3
2000 3
2001 3
2002 4
2003 4
2004 10
2005 12
2006 2
2007 2
2008 1
2009 3
2010 9
2011 8
2012 9
2013 6
2014 5
2015 10
2016 9
2017 2
2018 8
2019 4
2020 9
2021 10
2022 11
2023 10
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS; VX17-445-103 Trial Group. Heijerman HGM, et al. Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31. Lancet. 2019. PMID: 31679946 Free PMC article. Clinical Trial.
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Keating C, Yonker LM, Vermeulen F, Prais D, Linnemann RW, Trimble A, Kotsimbos T, Mermis J, Braun AT, O'Carroll M, Sutharsan S, Ramsey B, Mall MA, Taylor-Cousar JL, McKone EF, Tullis E, Floreth T, Michelson P, Sosnay PR, Nair N, Zahigian R, Martin H, Ahluwalia N, Lam A, Horsley A; VX20-121-102 Study Group; VX20-121-103 Study Group. Keating C, et al. Lancet Respir Med. 2025 Mar;13(3):256-271. doi: 10.1016/S2213-2600(24)00411-9. Epub 2025 Jan 2. Lancet Respir Med. 2025. PMID: 39756424 Free PMC article. Clinical Trial.
Sleep in Infants.
Hong H, Maloney MA, Keens TG, Perez IA. Hong H, et al. Among authors: keens tg. Am J Respir Crit Care Med. 2018 Oct 15;198(8):P15-P16. doi: 10.1164/rccm.1988P15. Am J Respir Crit Care Med. 2018. PMID: 30320526 No abstract available.
Prenatal substance abuse.
Ward SL, Keens TG. Ward SL, et al. Among authors: keens tg. Clin Perinatol. 1992 Dec;19(4):849-60. Clin Perinatol. 1992. PMID: 1464194 Review.
Congenital hypoventilation syndromes.
Lesser DJ, Ward SL, Kun SS, Keens TG. Lesser DJ, et al. Among authors: keens tg. Semin Respir Crit Care Med. 2009 Jun;30(3):339-47. doi: 10.1055/s-0029-1222448. Epub 2009 May 18. Semin Respir Crit Care Med. 2009. PMID: 19452394 Review.
SIDS research.
Keens TG, Ward SL. Keens TG, et al. Science. 1994 May 20;264(5162):1065. doi: 10.1126/science.8178159. Science. 1994. PMID: 8178159 No abstract available.
244 results